Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by Mbxwatcheron Apr 19, 2023 3:31pm
112 Views
Post# 35403673

RE:Nine shares

RE:Nine shares

stock is absolutely dead, until something happens.
Any momentum they had through the pandemic is gone.

Even a statement about Kinlytic (which would be great), was really not absorbed.......

We, (you and I included), gave them the benefit of the doubt after the poor first quarter,
Honestly though, even if Q2 results are not good, I have to say i firmly expected much more momentum in terms of deal making in QAPS, something, anything in VTM, and of course the long awaited much anticipated Kinlytic deal.

This is dormant or worse until we get something positive to chew on.
 

<< Previous
Bullboard Posts
Next >>